Dallas-Fort Worth Life Sciences – BioTech Guide
  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact
Tag:

dallas biotech

  • NEWS

    UTSW Biochemist to Receive Prestigious 2026 Japan Prize

    by ddankesreiter@dallaschamber.org February 12, 2026
    by ddankesreiter@dallaschamber.org February 12, 2026

    Zhijian “James” Chen, Ph.D., a professor of molecular biology at UT Southwestern Medical Center, is receiving the 2026 Japan Prize in Life Sciences. Recognized as one of the world’s top …

    0 FacebookTwitterPinterestEmail
  • NEWS

    New CEO at Biotech, Gradalis

    by ddankesreiter@dallaschamber.org January 16, 2026
    by ddankesreiter@dallaschamber.org January 16, 2026

    Carrollton-based Gradalis, Inc., a clinical-stage biotechnology company developing personalized anti-cancer therapies, has named Steven D. Weinstein as its new chief executive officer. Weinstein brings more than 20 years as a …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWS

    ARPA-H Award to UTSW to Bioengineer Livers

    by ddankesreiter@dallaschamber.org January 14, 2026
    by ddankesreiter@dallaschamber.org January 14, 2026

    UT Southwestern Medical Center will get up to $25 million from the Advanced Research Projects Agency for Health (ARPA-H) to create fully functional, patient-specific artificial livers that could ease the …

    0 FacebookTwitterPinterestEmail
  • NEWS

    New Biomanufacturing Training and Research Hub

    by ddankesreiter@dallaschamber.org January 13, 2026
    by ddankesreiter@dallaschamber.org January 13, 2026

    UTA and the Texas A&M Engineering Experiment Station have opened a new biomanufacturing training and research hub at Pegasus Park focused on workforce training and early-stage biotech development. The National …

    0 FacebookTwitterPinterestEmail
  • NEWS

    NTX Biotech Preps for Rare Pediatric Brain Cancer Trial

    by ddankesreiter@dallaschamber.org October 31, 2025
    by ddankesreiter@dallaschamber.org October 31, 2025

    Lantern Pharma Inc. (Nasdaq: LTRN) said it plans to launch a clinical trial in early 2026 for a rare pediatric brain cancer, following what it called an “optimistic meeting” with the …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWS

    Where Computer Science Meets Life Science

    by ddankesreiter@dallaschamber.org September 12, 2025
    by ddankesreiter@dallaschamber.org September 12, 2025

    University of Texas at Arlington computer science professor, Junzhou Huang, has secured $3.1 million in federal funding to tackle one of medicine’s most time-consuming challenges: figuring out which antibodies will …

    0 FacebookTwitterPinterestEmail
  • NEWS

    India-based pharma company to bring U.S. HQ to Mansfield

    by ddankesreiter@dallaschamber.org August 26, 2025
    by ddankesreiter@dallaschamber.org August 26, 2025

    Mansfield Economic Development Corp. and Stallion Labs, whose headquarters is in Ahmedabad, struck a deal on an economic incentive and performance agreement, which was approved and the council July 14. …

    0 FacebookTwitterPinterestEmail
  • NEWS

    Dallas Biotech’s new Tool Could Bring ‘Paradigm Shift’

    by ddankesreiter@dallaschamber.org August 25, 2025
    by ddankesreiter@dallaschamber.org August 25, 2025

    Only a small fraction of drugs can cross the blood-brain barrier–the layer that protects the brain from harmful substances. Usually a good thing, it also makes it harder to treat …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWS

    $30M Merger Creates Next-Gen #Biotech Company

    by ddankesreiter@dallaschamber.org August 25, 2025
    by ddankesreiter@dallaschamber.org August 25, 2025

    A $30 million merger among Community Direct DX (CDx), Scienetix, and the R&D division of Advanta Genetics has formed McKinney-based OSPRI, a next-generation biotechnology company and “one of the world’s …

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    North Texas AI-Driven Oncology Platform Files for IPO

    by ddankesreiter@dallaschamber.org June 5, 2025
    by ddankesreiter@dallaschamber.org June 5, 2025

    Irving-based Caris Life Sciences, a leader in AI-driven precision oncology, has filed for an initial public offering. Founded in 2008 by entrepreneur David D. Halbert, Caris was born from a …

    0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Opsin Biotherapeutics Awarded $2.35 Million NIH Grant to Advance Optogenetic Neuromodulation for Chronic Pain
  • Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program
  • UTSW receives ARPA-H award to create functioning artificial liver: Newsroom – UT Southwestern, Dallas, Texas
  • MusiQ Bio Lands $2.6M CPRIT Grant for Cancer Immunotherapy
  • MassChallenge Deepens Dallas Commitment with LHP

Recent Comments

No comments to show.

Social Connect

Facebook Twitter Instagram Pinterest Linkedin Youtube

Recent Posts

  • Opsin Biotherapeutics Awarded $2.35 Million NIH Grant to Advance Optogenetic Neuromodulation for Chronic Pain

  • Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program

  • UTSW receives ARPA-H award to create functioning artificial liver: Newsroom – UT Southwestern, Dallas, Texas

  • MusiQ Bio Lands $2.6M CPRIT Grant for Cancer Immunotherapy

  • MassChallenge Deepens Dallas Commitment with LHP

Categories

  • INVESTMENT (91)
  • NEWS (74)
  • RANKING (4)
  • RELOCATION (24)
  • Uncategorized (10)

CONTACT US

The Dallas Regional Chamber's Economic Development team serves as a single point of contact for companies, site selection consultants and corporate real estate executives examining the region for new and expanding companies.

  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact
Dallas-Fort Worth Life Sciences – BioTech Guide
  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact
  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact